Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With High Risk Coronary Artery Disease (FORWARD)

NCT04087915 · clinicaltrials.gov ↗
UNKNOWN
Status
1000
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Beijing Anzhen Hospital